The most common antigens targeted by NSCLC include EGFR (142), mesothelin (MSLN) (143), carcinoembryonic antigen (CEA) (144), PD-L1 (145), human epidermal growth factor receptor 2 (HER2) (146), etc. CAR T cells bind to the antigens of NSCLC to treat NSCLC. Here, CEACAM5 is linked to non-small cell lung carcinoma.